Position in ACRS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$282,753
+$66,623 QoQ
Shares Held
75,401
+5.0% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 30.74760281693877.ToString("F0")%
Shared 0.ToString("F0")%
None 69.25239718306123.ToString("F0")%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. ACRS ranks #184 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in ACRS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $282,753 | 75,401 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $216,130 | 71,804 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $173,348 | 91,236 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $120,650 | 84,965 | Shares | Sole | 2025-08-12 | |
| 2024-06-30 | $46,205 | 42,005 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $120,552 | 97,220 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $100,537 | 95,750 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $701,672 | 102,434 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,081,870 | 104,327 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $709,946 | 87,756 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,352,326 | 85,862 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,314,164 | 83,492 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,005,106 | 71,999 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $951,544 | 55,194 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $679,381 | 46,725 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $815,418 | 45,301 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $735,166 | 41,866 | Shares | Sole | 2021-08-05 | |
| 2020-03-31 | $53,691 | 51,626 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||